Evidence map›Paper›PMID 34888646›Full record

ArticleHuman molecular genetics2022

Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.

Chao-Jen Wong, Jennifer L Whiddon, Ashlee T Langford, Andrea E Belleville, Stephen J Tapscott

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. IncreasedInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chao-Jen WongDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Jennifer L WhiddonDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Ashlee T LangfordComparative Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Andrea E BellevilleDivisions of Public Health Sciences and Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Stephen J TapscottDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.ORCID 0000-0002-0319-0968
Fred Hutch Cancer Center · US

Funding

CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HEIMFELD, SHELLY · 1999 to 2014
$14.9M
MYOTONIC DYSTROPHY LOCUS CONTROLR01AR045203 · NIAMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TAPSCOTT, STEPHEN J · 1998 to 2025
$9.4M
NIAMS NIH HHS R01 AR045203NIAMS NIH HHS R01AR045203NIDDK NIH HHS P30 DK056465
6 · The paper itself

Abstract

Mis-expression of DUX4 in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). Human DUX4 and mouse Dux are retrogenes derived from retrotransposition of the mRNA from the parental DUXC gene. Primates and rodents have lost the parental DUXC gene, and it is unknown whether DUXC had a similar role in driving an early pluripotent transcriptional program. Dogs and other Laurasiatherians have retained DUXC, providing an opportunity to determine the functional similarity to the retrotransposed DUX4 and Dux. Here, we identify the expression of two isoforms of DUXC mRNA in canine testis tissues: one encoding the canonical double homeodomain protein (DUXC), similar to DUX4/Dux, and a second that includes an in-frame alternative exon that disrupts the conserved amino acid sequence of the first homeodomain (DUXC-ALT). The expression of DUXC in canine cells induces a pluripotent program similar to DUX4 and Dux and induces the expression of a similar set of retrotransposons of the ERV/MaLR and LINE-1 families, as well as pericentromeric satellite repeats; whereas DUXC-ALT did not robustly activate gene expression in these assays. Important for preclinical models of FSHD, human DUX4 and canine DUXC show higher conservation of their homeodomains and corresponding binding motifs compared with the conservation between human DUX4 and mouse Dux, and human DUX4 activates a highly similar transcriptional program in canine cells. Together, these findings show that retrotransposition resulted in the loss of an alternatively spliced isoform and that DUXC containing mammals might be good candidates for certain preclinical models ofFSHD.

Indexed as

Muscular Dystrophy, FacioscapulohumeralAmino Acid SequenceAnimalsDogsHomeodomain ProteinsMaleMammalsMiceMuscle, SkeletalRetroelementsRNA, MessengerDux4 protein, mouseHomeodomain ProteinsRetroelementsRNA, Messenger

Identifiers

PMID34888646
PMCPMC9122657
OpenAlexW4200125192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.